cefuroxime
Drugpreoperative intravenous 1.5g cefuroxime
NCT Number: NCT00530400
The purpose of the study is to determine whether a single, pre-operative dose of cefuroxime is effective in preventing surgical site infection in patients undergoing surgery for herniated disk
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Phase 4
Hôpitaux Universitaire de Genève, Geneva, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
preoperative intravenous 1.5g cefuroxime
preoperative intravenous placebo
Time frame: 6 months
Time frame: 6 monts
Time frame: 6 months
Centre Hospitalier Universitaire Vaudois
Other
Prospective, Double-Blind, Randomized, Placebo-Controlled Trial of Single-Dose Cefuroxime Prophylaxis in Herniated Disk Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05455801
Complication,Postoperative, Infections
Oviedo, Principality of Asturias, Spain
View Trial DetailsNCT07688109
Appendicitis, Cecal Diseases
Sanaa, Yemen
View Trial DetailsNCT07651462
Arthritis, Arthroplasty, Replacement, Hip
Berlin, State of Berlin, Germany
View Trial DetailsNCT07524062
Infections, Neoplasms
Leuven, Vlaams Brabant, Belgium
View Trial Details